BOULDER, CO, November 14, 2017 – AmideBio LLC, a privately held biopharmaceutical company, announced today that Charles A. Stanley MD will join its scientific advisory board. Dr. Stanley is a …
Dr. David L. Snitman joins AMIDEBIO Business Advisory Board
BOULDER, CO, November 12, 2017 – AmideBio LLC, a privately-held biopharmaceutical company, announced today that Dr. David L. Snitman has joined its business advisory board. Dr. Snitman has extensive experience …
AMIDEBIO Closes $764,000 Equity Financing
AmideBio LLC, a privately-held biopharmaceutical company, announced today that it has closed a new private placement round of $764,000 of preferred equity financing. The proceeds will be used to further …
AMIDEBIO awarded NIH grant for hyperinsulinism program
AmideBio LLC, a biopharmaceutical company in Boulder that makes peptides used in research to discover therapies for diabetes, has received a $338,387 grant that it will use to further develop …
- Page 2 of 2
- 1
- 2